Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Burnier

Showing results (251-260 of 284) with videos related to

Pageof 29
Sort By:
British Journal of Clinical Pharmacology|December 1, 1981
RHC 3659: a new orally active angiotensin converting enzyme inhibitor in normal volunteersM Burnier, G A Turini, H R Brunner, et al.
Journal of Internal Medicine|July 4, 2023
Perspectives on improving blood pressure control to reduce the clinical and economic burden of hypertensionG Mancia, F P Cappuccio, M Burnier, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1988
Effects of a nonpressor dose of neuropeptide Y on cardiac output, regional blood flow distribution and plasma renin, vasopressin and catecholamine levelsJ F Aubert, M Burnier, B Waeber, et al.
The Journal of Clinical Endocrinology and Metabolism|March 11, 1975
Circulating estradiol, estrone and gonadotropin levels following the administration of orally active 17beta-estradiol in postmenopausal womenS S Yen, P L Martin, A M Burnier, et al.
Diabetologia|April 24, 2010
Effects of the peroxisome proliferator-activated receptor (PPAR)-gamma agonist pioglitazone on renal and hormonal responses to salt in diabetic and hypertensive individualsA Zanchi, M Maillard, F R Jornayvaz, et al.
Hypertension (Dallas, Tex. : 1979)|February 19, 1999
Adducin polymorphism affects renal proximal tubule reabsorption in hypertensionP Manunta, M Burnier, M D'Amico, et al.
Obstetrics and Gynecology|April 1, 1984
Estradiol, estrone, and gonadotropin levels after use of vaginal estradiolP L Martin, M O Greaney, A M Burnier, et al.
Journal of Hypertension|October 11, 2001
Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and goutG Würzner, J C Gerster, A Chiolero, et al.
Journal of Hypertension|April 29, 1998
Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patientsA Pechère-Bertschi, J Nussberger, L Decosterd, et al.
Renal Failure|May 9, 1998
Estimation of glomerular filtration rate by sinistrin clearance using various approachesT Buclin, R Sechaud, A P Bertschi, et al.
Pageof 29

Showing results (251-260 of 284) with videos related to

Sort By:
Pageof 29
British Journal of Clinical Pharmacology|December 1, 1981
RHC 3659: a new orally active angiotensin converting enzyme inhibitor in normal volunteersM Burnier, G A Turini, H R Brunner, et al.
Journal of Internal Medicine|July 4, 2023
Perspectives on improving blood pressure control to reduce the clinical and economic burden of hypertensionG Mancia, F P Cappuccio, M Burnier, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1988
Effects of a nonpressor dose of neuropeptide Y on cardiac output, regional blood flow distribution and plasma renin, vasopressin and catecholamine levelsJ F Aubert, M Burnier, B Waeber, et al.
The Journal of Clinical Endocrinology and Metabolism|March 11, 1975
Circulating estradiol, estrone and gonadotropin levels following the administration of orally active 17beta-estradiol in postmenopausal womenS S Yen, P L Martin, A M Burnier, et al.
Diabetologia|April 24, 2010
Effects of the peroxisome proliferator-activated receptor (PPAR)-gamma agonist pioglitazone on renal and hormonal responses to salt in diabetic and hypertensive individualsA Zanchi, M Maillard, F R Jornayvaz, et al.
Hypertension (Dallas, Tex. : 1979)|February 19, 1999
Adducin polymorphism affects renal proximal tubule reabsorption in hypertensionP Manunta, M Burnier, M D'Amico, et al.
Obstetrics and Gynecology|April 1, 1984
Estradiol, estrone, and gonadotropin levels after use of vaginal estradiolP L Martin, M O Greaney, A M Burnier, et al.
Journal of Hypertension|October 11, 2001
Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and goutG Würzner, J C Gerster, A Chiolero, et al.
Journal of Hypertension|April 29, 1998
Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patientsA Pechère-Bertschi, J Nussberger, L Decosterd, et al.
Renal Failure|May 9, 1998
Estimation of glomerular filtration rate by sinistrin clearance using various approachesT Buclin, R Sechaud, A P Bertschi, et al.
Pageof 29